A glycosylphosphatidylinositol-based treatment alleviates trypanosomiasis-associated immunopathology

Journal of Immunology

Volumn 179, Issue 6, 2007, Pages 4003-4014

  Stijlemans, Benoît ^a,b   Baral, Toya Nath ^a,b   Guilliams, Martin ^a,b   Brys, Lea ^a,b   Korf, Johanna ^c   Drennan, Michael ^a,b   Van Den Abbeele, Jan ^d   De Baetselier, Patrick ^a,b   Magez, Stefan ^a,b  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c PASTEUR INSTITUTE OF BRUSSELS   (Belgium)

^d INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR; AUTACOID; CD1 ANTIGEN; CD1D ANTIGEN; VARIANT SURFACE GLYCOPROTEIN;

ACIDOSIS; AFRICAN TRYPANOSOMIASIS; ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG ACTIVITY; IMMUNOPATHOLOGY; LIVER INJURY; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TRYPANOSOMA BRUCEI; WEIGHT REDUCTION; ANIMAL; BAGG ALBINO MOUSE; C3H MOUSE; C57BL MOUSE; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; IMMUNOLOGY; LYMPHOCYTOPENIA; MOUSE MUTANT; PARASITOLOGY; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANEMIA; ANIMALS; ANTIGENS, CD1; B-LYMPHOCYTE SUBSETS; DISEASE MODELS, ANIMAL; GLYCOSYLPHOSPHATIDYLINOSITOLS; INFLAMMATION MEDIATORS; LYMPHOPENIA; MACROPHAGE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS, AFRICAN; VARIANT SURFACE GLYCOPROTEINS, TRYPANOSOMA;

EID: 35748961998     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.6.4003     Document Type: Article

References (66)

1. Hill, E. W., G. M. O'Gorman, M. Agaba, J. P. Gibson, O. Hanotte, S. J. Kemp, J. Naessens, P. M. Coussens, and D. E. MacHugh. 2005. Understanding bovine trypanosomiasis and trypanotolerance: the promise of functional genomics. Vet. Immunol. Immunopathol. 105: 247-258.
2. Chappuis, F., L. Loutan, P. Simarro, V. Lejon, and P. Buscher. 2005. Options for field diagnosis of human African trypanosomiasis. Clin. Microbiol. Rev. 18: 133-146.
3. Anene, B. M., D. N. Onah, and Y. Nawa. 2001. Drug resistance in pathogenic African trypanosomes: what hopes for the future? Vet. Parasitol. 96: 83-100.
4. Matovu, E., T. Seebeck, J. C. Enyaru, and R. Kaminsky. 2001. Drug resistance in Trypanosoma brucei spp., the causative agents of sleeping sickness in man and nagana in cattle. Microbes Infect. 3: 763-770.
5. Mulla, A. F., and L. R. Rickman. 1988. How do African game animals control trypanosome infections? Parasitol. Today 4: 352-354.
6. Vanhamme, L., E. Pays, R. McCulloch, and J. D. Barry. 2001. An update on antigenic variation in African trypanosomes. Trends Parasitol. 17: 338-343.
7. McCulloch, R. 2004. Antigenic variation in African trypanosomes: monitoring progress. Trends Parasitol. 20: 117-121.
8. Paulnock, D. M., and S. P. Coller. 2001. Analysis of macrophage activation in African trypanosomiasis. J. Leukocyte Biol. 69: 685-690.
9. Sternberg, J. M. 1998. Immunobiology of African trypanosomiasis. Chem. Immunol. 70: 186-199.
10. Sileghem, M., R. Saya, D. J. Grab, and J. Naessens. 2001. An accessory role for the diacylglycerol moiety of variable surface glycoprotein of African trypanosomes in the stimulation of bovine monocytes. Vet. Immunol. Immunopathol. 78: 325-339.
11. Tachado, S. D., and L. Schofield. 1994. Glycosylphosphatidylinositol toxin of Trypanosoma brucei regulates IL-1 α and TNF-α expression in macrophages by protein tyrosine kinase mediated signal transduction. Biochem. Biophys. Res. Commun. 205: 984-991.
12. Magez, S., B. Stijlemans, M. Radwanska, E. Pays, M. A. Ferguson, and P. De Baetselier. 1998. The glycosyl-inositol-phosphate and dimyristoylglycerol moieties of the glycosylphosphatidylinositol anchor of the trypanosome variant-specific surface glycoprotein are distinct macrophage-activating factors. J. Immunol. 160: 1949-1956.
13. Almeida, I. C., M. M. Camargo, D. O. Procopio, L. S. Silva, A. Mehlert, L. R. Travassos, R. T. Gazzinelli, and M. A. Ferguson. 2000. Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents. EMBO J. 19: 1476-1485.
14. Mensa-Wilmot, K., N. Garg, B. S. McGwire, H. G. Lu, L. Zhong, D. A. Armah, J. H. LeBowitz, and K. P. Chang. 1999. Roles of free GPIs in amastigotes of Leishmania. Mol. Biochem. Parasitol. 99: 103-116.
15. Magez, S., B. Stijlemans, T. Baral, and P. De Baetselier. 2002. VSG-GPI anchors of African trypanosomes: their role in macrophage activation and induction of infection-associated immunopathology. Microbes Infect. 4: 999-1006.
16. Tachado, S. D., P. Gerold, M. J. McConville, T. Baldwin, D. Quilici, R. T. Schwarz, and L. Schofield. 1996. Glycosylphosphatidylinositol toxin of Plasmodium induces nitric oxide synthase expression in macrophages and vascular endothelial cells by a protein tyrosine kinase-dependent and protein kinase C-dependent signaling pathway. J. Immunol. 156: 1897-1907.
17. Naik, R. S., O. H. Branch, A. S. Woods, M. Vijaykumar, D. J. Perkins, B. L. Nahlen, A. A. Lal, R. J. Cotter, C. E. Costello, C. F. Ockenhouse, et al. 2000. Glycosylphosphatidylinositol anchors of Plasmodium falciparum: molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis. J. Exp. Med. 192: 1563-1576.
18. Perraut, R., B. Diatta, L. Marrama, O. Garraud, R. Jambou, S. Longacre, G. Krishnegowda, A. Dieye, and D. C. Gowda. 2005. Differential antibody responses to Plasmodium falciparum glycosylphosphatidylinositol anchors in patients with cerebral and mild malaria. Microbes Infect. 7: 682-687.
19. Schofield, L., M. C. Hewitt, K. Evans, M. A. Siomos, and P. H. Seeberger. 2002. Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria. Nature 418: 785-789.
20. Tachado, S. D., P. Gerold, R. Schwarz, S. Novakovic, M. McConville, and L. Schofield. 1997. Signal transduction in macrophages by glycosylphosphatidylinositols of Plasmodium, Trypanosoma, and Leishmania: activation of protein tyrosine kinases and protein kinase C by inositolglycan and diacylglycerol moieties. Proc. Natl. Acad. Sci. USA 94: 4022-4027.
21. Stijlemans, B., K. Conrath, V. Cortez-Retamozo, H. Van Xong, L. Wyns, P. Senter, H. Revets, P. De Baetselier, S. Muyldermans, and S. Magez. 2004. Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies: African trypanosomes as paradigm. J. Biol. Chem. 279: 1256-1261.
22. Schell, D., and P. Overath. 1990. Purification of the membrane-form variant surface glycoprotein of Trypanosoma brucei. J. Chromatogr. 521: 239-243.
23. Cross, G. A. 1984. Release and purification of Trypanosoma brucei variant surface glycoprotein. J. Cell. Biochem. 24: 79-90.
24. Zamze, S. E., M. A. Ferguson, R. Collins, R. A. Dwek, and T. W. Rademacher. 1988. Characterization of the cross-reacting determinant (CRD) of the glycosylphosphatidylinositol membrane anchor of Trypanosoma brucei variant surface glycoprotein. Eur J. Biochem. 176: 527-534.
25. Ferguson, M. A., K. Haldar, and G. A. Cross. 1985. Trypanosoma brucei variant surface glycoprotein has a sn-1,2-dimyristyl glycerol membrane anchor at its COOH terminus. J. Biol. Chem. 260: 4963-4968.
26. Bangham, A. D. 1972. Lipid bilayers and biomembranes. Annu. Rev. Biochem. 41: 753-776.
27. Schofield, L., M. J. McConville, D. Hansen, A. S. Campbell, B. Fraser-Reid, M. J. Grusby, and S. D. Tachado. 1999. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 283: 225-229.
28. Goodman, M. G., and W. O. Weigle. 1983. T cell-replacing activity of C8-derivatized guanine ribonucleosides. J. Immunol. 130: 2042-2045.
29. Mond, J. J., K. Hunter, J. J. Kenny, F. Finkelman, and K. Witherspoon. 1989. 8-Mercaptoguanosine-mediated enhancement of in vivo IgG1, IgG2 and IgG3 antibody responses to polysaccharide antigens in normal and xid mice. Immunopharmacology 18: 205-212.
30. Magez, S., M. Radwanska, A. Beschin, K. Sekikawa, and P. De Baetselier. 1999. Tumor necrosis factor α is a key mediator in the regulation of experimental Trypanosoma brucei infections. Infect. Immun. 67: 3128-3132.
31. Raes, G., L. Brys, B. K. Dahal, J. Brandt, J. Grooten, F. Brombacher, G. Vanham, W. Noel, P. Bogaert, T. Boonefaes, et al. 2005. Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation. J. Leukocyte Biol. 77: 321-327.
32. Naessens, J. 2006. Bovine trypanotolerance: a natural ability to prevent severe anaemia and haemophagocytic syndrome? Int. J. Parasitol. 36: 521-528.
33. Odeh, M. 2001. The role of tumour necrosis factor-α in the pathogenesis of complicated falciparum malaria. Cytokine 14: 11-18.
34. Magez, S., B. Stijlemans, G. Caljon, H. P. Eugster, and P. De Baetselier. 2002. Control of experimental Trypanosoma brucei infections occurs independently of lymphotoxin-α induction. Infect. Immun. 70: 1342-1351.
35. Sileghem, M., J. N. Flynn, L. Logan-Henfrey, and J. Ellis. 1994. Tumour necrosis factor production by monocytes from cattle infected with Trypanosoma (Duttonella) vivax and Trypanosoma (Nannomonas) congolense: possible association with severity of anaemia associated with the disease. Parasite Immunol. 16: 51-54.
36. Wicker, L. S., R. C. Boltz, Jr., E. A. Nichols, B. J. Miller, N. H. Sigal, and L. B. Peterson. 1987. Large, activated B cells are the primary B-cell target of 8-bromoguanosine and 8-mercaptoguanosine. Cell. Immunol. 106: 318-329.
37. Goodman, M. G. 1985. Demonstration of T-cell-dependent and T-cell-independent components of 8-mercaptoguanosine-mediated adjuvanticity. Proc. Soc. Exp. Biol. Med. 179: 479-486.
38. Magez, S., C. Truyens, M. Merimi, M. Radwanska, B. Stijlemans, P. Brouckaert, F. Brombacher, E. Pays, and P. De Baetselier. 2004. P75 tumor necrosis factor-receptor shedding occurs as a protective host response during African trypanosomiasis. J. Infect. Dis. 189: 527-539.
39. Tabel, H. 1982. Activation of the alternative pathway of bovine complement by Trypanosoma congolense. Parasite Immunol. 4: 329-335.
40. Witola, W. H., and C. E. Lovelace. 2001. Demonstration of erythrophagocytosis in Trypanosoma congolense-infected goats. Vet. Parasitol. 96: 115-126.
41. Baetselier, P. D., B. Namangala, W. Noel, L. Brys, E. Pays, and A. Beschin. 2001. Alternative versus classical macrophage activation during experimental African trypanosomosis. Int. J. Parasitol. 31: 575-587.
42. Shi, M., G. Wei, W. Pan, and H. Tabel. 2005. Impaired Kupffer cells in highly susceptible mice infected with Trypanosoma congolense. Infect. Immun. 73: 8393-8396.
43. Ghassabeh, G. H., P. De Baetselier, L. Brys, W. Noel, J. A. Van Ginderachter, S. Meerschaut, A. Beschin, F. Brombacher, and G. Raes. 2006. Identification of a common gene signature for type II cytokine-associated myeloid cells elicited in vivo in different pathologic conditions. Blood 108: 575-583.
44. Moschos, M. P. 2000. Selenoprotein P. Cell. Mol. Life Sci. 57: 1836-1845.
45. Muszbek, L., V. C. Yee, and Z. Hevessy. 1999. Blood coagulation factor XIII: structure and function. Thromb. Res. 94: 271-305.
46. Misasi, R., T. Garofalo, L. Di Marzio, V. Mattei, C. Gizzi, M. Hiraiwa, A. Pavan, M. Grazia Cifone, and M. Sorice. 2004. Prosaposin: a new player in cell death prevention of U937 monocytic cells. Exp. Cell Res. 298: 38-47.
47. Allavena, P., M. Chieppa, P. Monti, and L. Piemonti. 2004. From pattern recognition receptor to regulator of homeostasis: the double-faced macrophage mannose receptor. Crit. Rev. Immunol. 24: 179-192.
48. Zeng, Z., A. R. Castano, B. W. Segelke, E. A. Stura, P. A. Peterson, and I. A. Wilson. 1997. Crystal structure of mouse CD1: an MHC-like fold with a large hydrophobic binding groove. Science 277: 339-345.
49. Brutkiewicz, R. R. 2006. CD1d ligands: the good, the bad, and the ugly. J. Immunol. 177: 769-775.
50. Gimenez, F., S. Barraud de Lagerie, C. Fernandez, P. Pino, and D. Mazier. 2003. Tumor necrosis factor α in the pathogenesis of cerebral malaria. Cell. Mol. Life Sci. 60: 1623-1635.
51. Lucas, R., S. Magez, B. Songa, A. Darji, R. Hamers, and P. de Baetselier. 1993. A role for TNF during African trypanosomiasis: involvement in parasite control, immunosuppression and pathology. Res. Immunol. 144: 370-376.
52. Gerold, P., L. Vivas, S. A. Ogun, N. Azzouz, K. N. Brown, A. A. Holder, and R. T. Schwarz. 1997. Glycosylphosphatidylinositols of Plasmodium chabaudi chabaudi: a basis for the study of malarial glycolipid toxins in a rodent model. Biochem. J. 328: 905-911.
53. Channe Gowda, D. 2002. Structure and activity of glycosylphosphatidylinositol anchors of Plasmodium falciparum. Microbes Infect. 4: 983-990.
54. Bate, C. A., J. Taverne, E. Roman, C. Moreno, and J. H. Playfair. 1992. Tumour necrosis factor induction by malaria exoantigens depends upon phospholipid. Immunology 75: 129-135.
55. Zhu, J., G. Krishnegowda, and D. C. Gowda. 2005. Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: the requirement of extracellular signal-regulated kinase, p38, c-Jun N-terminal kinase and NF-κB pathways for the expression of proinflammatory cytokines and nitric oxide. J. Biol. Chem. 280: 8617-8627.
56. Schofield, L., and F. Hackett. 1993. Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites. J. Exp. Med. 177: 145-153.
57. Vijaykumar, M., R. S. Naik, and D. C. Gowda. 2001. Plasmodium falciparum glycosylphosphatidylinositol-induced TNF-α secretion by macrophages is mediated without membrane insertion or endocytosis. J. Biol. Chem. 276: 6909-6912.
58. Rolin, S., J. Hancocq-Quertier, F. Paturiaux-Hanocq, D. P. Nolan, and E. Pays. 1998. Mild acid stress as a differentiation trigger in Trypanosoma brucei. Mol. Biochem. Parasitol. 93: 251-262.
59. Coller, S. P., J. M. Mansfield, and D. M. Paulnock. 2003. Glycosylinositolphosphate soluble variant surface glycoprotein inhibits IFN-γ-induced nitric oxide production via reduction in STAT1 phosphorylation in African trypanosomiasis. J. Immunol. 171: 1466-1472.
60. Nyakundi, J. N., B. Crawley, R. A. Smith, and V. W. Pentreath. 2002. The relationships between intestinal damage and circulating endotoxins in experimental Trypanosoma brucei brucei infections. Parasitology 124: 589-595.
61. Namangala, B., P. De Baetselier, W. Noel, L. Brys, and A. Beschin. 2001. Alternative versus classical macrophage activation during experimental African trypanosomosis. J. Leukocyte Biol. 69: 387-396.
62. Mantovani, A., A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25: 677-686.
63. + hepatic dendritic cells in the induction of innate immune responses. Clin. Exp. Immunol.
64. Shi, H., M. V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J. S. Flier. 2006. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116: 3015-3025.
65. Proudfoot, L., A. V. Nikolaev, G. J. Feng, W. Q. Wei, M. A. Ferguson, J. S. Brimacombe, and F. Y. Liew. 1996. Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages. Proc. Natl. Acad. Sci. USA 93: 10984-10989.
66. Taiwo, V. O., and V. O. Anosa. 2000. In vitro erythrophagocytosis by cultured macrophages stimulated with extraneous substances and those isolated from the blood, spleen and bone marrow of Boran and N'Dama cattle infected with Trypanosoma congolense and Trypanosoma vivax. Onderstepoort. J. Vet. Res. 67: 273-287.